AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportRecursion Pharmaceuticals vs Nabla
VS
Recursion Pharmaceuticals
Enterprise
Nabla
4.8Freemium
Verdict by Category
Detailed category analysis is not available for this comparison.
Feature & Spec Matrix
Detailed Comparison25 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
Swipe horizontally to compare features
Feature / Spec
Pricing Model
Difference
EnterpriseAI-enabled drug discovery and mapping (Recursion OS) — Custom biopharma enterprise partnership agreements only
FreemiumFree tier with 30 consultations/mo (no card required) & 30-day trial — Pro $119/clinician/mo
Starting Price
Difference
Custom / Contact Sales
$119/mo
Free Plan & Trial Scope
Difference
No self-serve access — enterprise pharma collaborations and data licensing via partnership team
Free plan provides 30 free clinical consultations to test ambient SOAP note generation
User Rating Score
Difference
Unrated
4.8
Ideal Workflow / Use Case
Difference
Major pharma companies and researchers needing AI-powered biology mapping, target discovery, and drug candidate generation at industrial scale through the Recursion OS platform
Primary care physicians, urgent care clinics, mental health therapists, and hospitalists eliminating 2+ hours of evening EHR pajama charting
Enterprise & Scalability
Difference
NASDAQ listed (RXRX), $500M+ in pharma partnership milestones earned, enterprise collaboration agreements with Roche/Genentech and Sanofi, automated biology and chemistry labs at industrial scale in Salt Lake City and Oxford, and data licensing for external researchers
Ambient Clinical Voice AI (listens to natural doctor-patient dialogue in the exam room or telehealth and drafts structured SOAP notes in 15 seconds), Direct EHR Chrome Extension (1-click paste into Epic, Cerner, Athenahealth, eClinicalWorks, Elation), Automated Medical Billing & ICD-10 / CPT Code suggestions, Multi-Language Support (translates 55+ languages in real-time), and HIPAA / GDPR compliance with zero audio storage
Core Categories
Difference
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Recursion OS — AI-native end-to-end drug discovery platform integrating biology, chemistry, and clinical development
Difference
Recursion Pharmaceuticals Advantage
Not listed
Industrial-scale automated labs in Salt Lake City and Oxford generating proprietary multimodal data
Difference
Recursion Pharmaceuticals Advantage
Not listed
REC-4881 for FAP — 53% polyp reduction in Phase 2, FDA registration discussions begun 2026
Difference
Recursion Pharmaceuticals Advantage
Not listed
REC-1245 (RBM39 degrader) in Phase 1/2 DAHLIA study for solid tumors
Difference
Recursion Pharmaceuticals Advantage
Not listed
REC-4539 (LSD1 inhibitor) — first patient dosed in Phase 1 ENLYGHT study 2026
Difference
Recursion Pharmaceuticals Advantage
Not listed
Sanofi partnership — $134M earned to date across 5 milestones
Difference
Recursion Pharmaceuticals Advantage
Not listed
Roche/Genentech Phenomaps — 1 trillion neuronal cells for neuroscience target discovery
Difference
Recursion Pharmaceuticals Advantage
Not listed
$500M+ in cumulative pharma partnership milestones earned to date
Difference
Recursion Pharmaceuticals Advantage
Not listed
Recursion Data — phenomics and biology maps licensed to external researchers and pharma
Difference
Recursion Pharmaceuticals Advantage
Not listed
NASDAQ: RXRX — founded 2013; $74.7M revenue in 2025; acquired Exscientia in 2024
Difference
Recursion Pharmaceuticals Advantage
Not listed
Ambient AI documentation that listens to the patient encounter and generates a structured clinical note in seconds
Difference
Not listed
Nabla Advantage
Clinical-grade dictation embedded at-cursor inside Epic and other EHRs, with voice commands and dot phrases
Difference
Not listed
Nabla Advantage
AI-assisted E/M and ICD-10 coding suggestions grounded in AMA guidelines and the clinical documentation
Difference
Not listed
Nabla Advantage
Native EHR integrations via SMART on FHIR with Epic, athenahealth, Oracle Health, NextGen, and Greenway Health
Difference
Not listed
Nabla Advantage
Nabla Connect, a plug-and-play module that lets EHR vendors embed Nabla's ambient AI directly into their own platforms
Difference
Not listed
Nabla Advantage
Support for 35+ languages and 50+ medical specialties across in-person and telehealth encounters
Difference
Not listed
Nabla Advantage
Web, iOS, Android, and Chrome extension apps, plus a public developer API for custom integrations
Difference
Not listed
Nabla Advantage
Enterprise-grade security with HIPAA, SOC 2 Type 2, ISO 27001, and GDPR compliance and configurable data retention
Difference
Not listed
Nabla Advantage
Recursion Pharmaceuticals Pros & Cons
Pros
- $500M+ in pharma partnership milestones — most validated AI drug platform by commercial revenue
- Recursion OS is the most vertically integrated AI drug discovery system — biology to clinic in one platform
- Industrial-scale automated labs generate data no other company can replicate
- Phase 2 FAP clinical proof of concept — 53% polyp reduction — FDA registration discussions began
- Roche/Genentech and Sanofi as partners — two of the world's top 5 pharma companies
- Exscientia acquisition in 2024 added cutting-edge small molecule AI design capabilities
- Cash runway guided into early 2028 — disciplined capital allocation
Cons
- Stock (RXRX) is below $5 — significant market skepticism on timeline to commercial drugs
- Operating cash burn of ~$390M in 2026 — needs continued capital or milestone payments
- Acquired Exscientia in 2024 — integration complexity and added operational overhead
- No approved drugs yet — clinical proof of concept still early stage
- Proprietary platform requires industrial-scale automation infrastructure that can't be self-built
Nabla Pros & Cons
Pros
- Fast note generation, roughly five seconds, that closely mirrors real clinical documentation in independent tests
- Deep native integration with Epic and other major EHRs rather than copy-paste workflows
- Broad specialty and language coverage suited to large, diverse health systems
- Strong compliance posture (HIPAA, SOC 2 Type 2, ISO 27001, GDPR) with configurable data retention
- Backed by peer-reviewed evidence, including a NEJM AI randomized trial showing documentation-time reductions
- Combines documentation, dictation, and coding in one platform instead of separate point tools
Cons
- Pricing isn't published; individuals and smaller practices must go through a sales conversation or rely on third-party estimates to budget
- Primarily built for hospitals and health systems, so solo clinicians and small practices may find it less tailored than SMB-focused scribes
- Relies on ambient recording, so encounters where a patient or clinician can't or won't be recorded aren't well supported
- Some independent reviews note limited customization and quality drop-off on complex, multi-problem visits
- Mobile app store ratings are mixed and based on a relatively small number of reviews compared to the platform's overall clinician base
Head-to-Head Battle Cards
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels
AI Healthcare ToolsCompare
AI Healthcare ToolsCompare
AI Healthcare ToolsCompare
AI Healthcare ToolsCompare